1. Global Genomics Market Overview
2. Executive Summary
3. Global Genomics Market Landscape
   3.1. Market Share Analysis
   3.2. Comparative Analysis
      3.2.1. Product Benchmarking
      3.2.2. End user profiling
      3.2.3. Patent Analysis
      3.2.4. Top 5 Financials Analysis
4. Global Genomics Market Forces
   4.1. Market Drivers
   4.2. Market Constraints
   4.3. Market Challenges
   4.4. Attractiveness of the Genomics Industry
      4.4.1. Power of Suppliers
      4.4.2. Power of Customers
      4.4.3. Threat of New entrants
      4.4.4. Threat of Substitution
      4.4.5. Degree of Competition
5. Global Genomics Market – Strategic Analysis
   5.1. Value Chain Analysis
   5.2. Pricing Analysis
   5.3. Opportunities Analysis
   5.4. Product/Market Life Cycle Analysis
   5.5. Suppliers and Distributors
6. Global Genomics Market – Product Types Analysis
   6.1. Introduction
   6.2. Products
      6.2.1. DNA Microarrays
      6.2.2. Electrophoresis
      6.2.3. X-Ray Crystallography
      6.2.4. Polymerase Chain Reaction (PCR)
      6.2.5. DNA Sequencers
            6.2.5.1. 1st Generation
            6.2.5.2. 2nd Generation
            6.2.5.3. 3rd Generation
            6.2.5.4. Next Generation
      6.2.6. Chromotography
   6.3. Reagents Used
7. Global Genomics Market - Service Industry Analysis
   7.1. Introduction
   7.2. Bio-informatics Database
   7.3. Bio-informatics Tools
   7.4. Laboratory Services
      7.4.1. DNA Sample Sequencing
      7.4.2. De Novo Sequencing
      7.4.3. Targeted Re-sequencing
      7.4.4. Individual Genome Sequencing
      7.4.5. SNPS Analysis
      7.4.6. Molecular Biology
      7.4.7. Gene Expression Analysis
      7.4.8. Genotyping Service
      7.4.9. Biomarker Solutions
8. Global Genomics Market – End Use Applications Analysis
   8.1. Introduction 
   8.2. Anthropology
   8.3. Agriculture
   8.4. Cytogenetics
   8.5. Diagnostics
   8.6. Drug Discovery
   8.7. Toxicogenomics
   8.8. Others
9. Global Genomics Market – Geographic Analysis
   9.1. Introduction 
   9.2. Americas
      9.2.1. North America
      9.2.2. Brazil
      9.2.3. Argentina
      9.2.4. Mexico
   9.3. Europe
      9.3.1. UK
      9.3.2. France
      9.3.3. Germany
   9.4. APAC
      9.4.1. China
      9.4.2. South Korea
      9.4.3. Japan
      9.4.4. Australia
   9.5. ROW
10. Genomics Market Entropy
   10.1. New Product Launches
   10.2. M&As, Collaborations, JVs and Partnerships
11. Investment Opportunities – Analysis by Target companies/customers, Capital Investments, ROI, Payback Period and Source of Funds.
12. Company Reports (Overview, Financials, SWOT Analysis, Developments, Product Portfolio)
   12.1. Affymetrix
   12.2. Agilent Technologies
   12.3. Applied Biosystems Group
   12.4. Bayer AG
   12.5. Bio-Rad Laboratories
   12.6. Caliper Life Sciences
   12.7. Cepheid
   12.8. Complete Genomics
   12.9. Existence Genetics
   12.10. GE Healthcare
   12.11. GeneWiz Inc
   12.12. Illumina Inc
   12.13. Luminex Corporation
   12.14. Myriad Genetics
   12.15. Navigenics
   12.16. Pacific Biosciences
   12.17. Qiagen Inc
   12.18. Roche Diagnostics
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
13. Appendix
   13.1. Abbreviations
   13.2. Sources
   13.3. Research Methodology
   13.4. Bibliography
   13.5. Compilation of Expert Insights
   13.6. Disclaimer